It seems to me so much of drug development for male pattern baldness has been stuck in the stone age of trying to crudely suppress androgenic activity without anyone really asking why the AR receptors in the scalp in balding men are acting in a dysfunctional manner.
We have Cots's PGD2 angle, but afaik, PGD2 being overproduced is a downstream effect of dysfunctional androgen activity in the follicle
what has been done so far to attempt to identify why beyond "lol its genes"? I am grossly simplifying for the sake of brevity of course, but all antiandrogen treatments to me seem like trying to perform micro surgery with a shotgun.
We have Cots's PGD2 angle, but afaik, PGD2 being overproduced is a downstream effect of dysfunctional androgen activity in the follicle
what has been done so far to attempt to identify why beyond "lol its genes"? I am grossly simplifying for the sake of brevity of course, but all antiandrogen treatments to me seem like trying to perform micro surgery with a shotgun.
